GHK-Cu is unusually well-positioned here
At Better Med Spa & Wellness in Lincoln Park, Chicago, BPC-157 is prescribed by a licensed medical provider, sourced exclusively from a 503A compounding pharmacy (never research grade), and available in 4-week or 8-week treatment options
Diabetic Retinopathy Models and BPC-157 Diabetic retinopathy (DR) involves a cascade of microvascular and neuronal pathology: pericyte loss (early hallmark, precedes endothelial dysfunction), BRB breakdown (tight junction protein claudin-5/occludin/ZO-1 loss), microaneurysm formation, acellular capillary development, and ultimately neovascularisation in proliferative DR
Multiple clinical trials and controlled studies have demonstrated: Statistically significant improvements in skin firmness and elasticity with consistent use Reduction in fine lines and wrinkle depth over 3-6 months of application Improved skin density, moisture retention, and surface texture Reduction in photodamage and hyperpigmentation Tightening of loose skin documented in both topical and injectable applications Citation: Leyden JJ et al
OBrien JT, Ames D, Schweitzer I et al (1996) Enhanced adrenal sensitivity to adrenocorticotrophic hormone (ACTH) is evidence of HPA axis hyperactivity in Alzheimers disease